Gilead Sciences


Gilead Sciences Stock Quote
$63.44 -$0.67 -1.0%
BATS BZX Real Time Price as of August 20, 2019, 4:00 p.m. EDT View Interactive GILD Charts

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

News & Analysis: Gilead Sciences

The Fool has written over 1400 articles on Gilead Sciences.


Market Moves



What Happened in the Stock Market Today

From failed takeover talks to a massive new partnership, see why these stocks were on the move on a quiet day for the broader markets.

Interactive Chart